Creatinine Assay Kits Market - Emerging Industry Trends & Global Future Forecasts

Target Audience for this Report:

# Creatinine assay kit manufacturers
# Creatinine assay kit distributors
# Hospitals
# Research and consulting firms
# Venture capitalists
# Regulatory bodies
# Academic centers
# Teaching hospitals and academic medical centers (AMCs)
# Contract manufacturing organizations (CMOs)
# Contract research organizations (CROs)

The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%. 

Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are the key drivers of the global creatinine assay kits market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73499229

The objectives of this study are as follows:

# To define, describe, and forecast the global creatinine assay kits on the basis of type, type of sample, and region.

# To estimate the total number of Creatinine Measurement tests conducted by type and region.

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders.

# To forecast the size of the market with respect to five regions: North America, Europe, Asia, and the Rest of the World (RoW).

# To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments in the creatinine assay kits industry, such as acquisitions, agreements, product launches & upgrades, expansions, and R&D activities.

In 2017, North America dominated the creatinine assay kits market

In 2017, North America dominated the market followed by Europe. The large share of North America is attributed to factors such as increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction), and the implementation of favorable government initiatives to increase awareness of and encourage research pertaining to kidney diseases.

The creatinine assay kits market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Crystal Chem (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US).

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=73499229

Agreements, acquisitions, and expansions accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Thermo Fisher Scientific (US), Merck (Germany), Abcam (UK), Abbott Laboratories (US), and Cayman Chemical (US).